Urinary, bowel and sexual health in older men from Northern Ireland-Reference-Cited by-同舟云学术

Urinary, bowel and sexual health in older men from Northern Ireland

Published:2018-03-25 Issue:5 Volume:122 Page:845-857
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Donnelly David W.¹^ORCID,Donnelly Conan²,Kearney Therese¹,Weller David³,Sharp Linda⁴,Downing Amy⁵,Wilding Sarah⁵,Wright Penny⁵^ORCID,Kind Paul⁶,Catto James W.F.⁷,Cross William R.⁸,Mason Malcolm D.⁹,McCaughan Eilis¹⁰,Wagland Richard¹¹,Watson Eila¹²,Mottram Rebecca⁵,Allen Majorie⁵,Butcher Hugh¹³,Hounsome Luke¹⁴,Selby Peter⁵,Huws Dyfed¹⁵,Brewster David H.¹⁶,McNair Emma¹⁶,Rivas Carol¹⁷,Nayoan Johana¹¹,Horton Mike¹⁸,Matheson Lauren¹²,Glaser Adam W.⁵,Gavin Anna¹

Affiliation:

1. Northern Ireland Cancer Registry; Centre for Public Health; Queen's University Belfast; Belfast UK

2. National Cancer Registry Ireland; Cork Ireland

3. Centre for Population Health Sciences; University of Edinburgh; Edinburgh UK

4. Institute of Health and Society; Newcastle University; Newcastle upon Tyne UK

5. Leeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics; University of Leeds; Leeds UK

6. Institute of Health Sciences; University of Leeds; Leeds UK

7. Academic Urology Unit; University of Sheffield; Sheffield UK

8. Department of Urology; St James's University Hospital; Leeds UK

9. Division of Cancer and Genetics; School of Medicine; Velindre Hospital; Cardiff University; Cardiff UK

10. Institute of Nursing and Health Research; Ulster University; Coleraine UK

11. Faculty of Health Sciences; University of Southampton; Southampton UK

12. Faculty of Health and Life Sciences; Oxford Brookes University; Oxford UK

13. Yorkshire Cancer Patient Forum; c/o Strategic Clinical Network and Senate; Yorkshire and The Humber; Harrogate UK

14. National Cancer Registration and Analysis Service; Public Health England; Bristol UK

15. Welsh Cancer Intelligence and Surveillance Unit; Cardiff UK

16. Information Services Division; NHS National Services Scotland; Edinburgh UK

17. Department of Social Science; UCL Institute of Education; University College London; London UK

18. Psychometric Laboratory for Health Sciences; Academic Department of Rehabilitation Medicine; University of Leeds; Leeds UK

Funder

Prostate Cancer UK

Movember Foundation

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14182/fullpdf

Reference39 articles.

1. Northern Ireland Cancer Registry Prostate cancer http://www.qub.ac.uk/research-centres/nicr/cancerinformation/official-statistics/bysite/prostate.html

2. Cancer Research UK Prostate cancer incidence statistics http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence

3. Prostate cancer outcomes: the three questions;Glaser;Eur Urol,2015

4. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7);Rosen;Eur Urol,2003

5. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study;Coyne;BJU Int,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between obesity and urinary incontinence in older adults from multiple nationwide longitudinal cohorts;Communications Medicine;2023-10-11

2. Prevalence, lifestyle, and risk factors of erectile dysfunction, premature ejaculation, and low libido in middle‐aged men: first results of the Bavarian Men's Health‐Study;Andrology;2023-09-07

3. A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy;Cancers;2023-08-09

4. BMI, waist circumferences and urinary incontinence in older women compared with older men: findings from three prospective longitudinal cohort studies;2023-01-17

5. Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population;Clinical and Translational Radiation Oncology;2022-11